These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 7010179
1. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations. Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179 [No Abstract] [Full Text] [Related]
7. [Present strategy for new drug development in the USA]. Shimada Y. Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():315-24. PubMed ID: 7986110 [Abstract] [Full Text] [Related]
13. The linear array. Zubrod CG, Schepartz SA, Carter SK. Natl Cancer Inst Monogr; 1977 Mar; (45):13-4. PubMed ID: 927488 [No Abstract] [Full Text] [Related]
14. Historical background of the National Cancer Institute's drug development thrust. Zubrod CG, Schepartz SA, Carter SK. Natl Cancer Inst Monogr; 1977 Mar; (45):7-11. PubMed ID: 337156 [No Abstract] [Full Text] [Related]
15. The role of the National Cancer Institute in drug development. Doroshow J. Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997 [No Abstract] [Full Text] [Related]
17. Drug development in the United States and U.S.S.R.: commentary on the cooperative accomplishments. Zubrod CG, Blokhin NN. Natl Cancer Inst Monogr; 1977 Mar; (45):5-6. PubMed ID: 927494 [No Abstract] [Full Text] [Related]
19. Laetrilomania--again. Relman AS. N Engl J Med; 1978 Jan 26; 298(4):215-6. PubMed ID: 339088 [No Abstract] [Full Text] [Related]
20. The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary. Venditti JM. Cancer Treat Rep; 1983 Sep 26; 67(9):767-72. PubMed ID: 6883352 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]